Can syringe exchange serve as a conduit to substance abuse treatment?

被引:82
作者
Heimer, R [1 ]
机构
[1] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA
关键词
needle/syringe exchange; substance abuse treatment; HIV/AIDS prevention; managed care;
D O I
10.1016/S0740-5472(97)00220-1
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
To determine how the city-run New Haven syringe exchange program (SEP) expedited requests for entry into treatment, records of the SEP's drug treatment coordinator were analyzed. During the study period, a majority of those requesting treatment did not use the SEP to obtain sterile syringes. Comparisons between the people requesting treatment and those exchanging syringes revealed that those requesting treatment were more likely female and less likely White. Factors associated with failure to enter treatment included long lag times, worse insurance, cocaine use, and requesting primary detoxification only. Majorities of the requests, appointments, and entries came from individuals whose treatment was to be paid through city welfare. A managed care initiative from the city welfare department, which excluded the SEP, halved requests and entries. Subsequent addition of the SEP to the initiative did not significantly increase requests or entries. Although the SEP initially acted as a conduit to treatment, its effectiveness was curtailed by the imposition of bureaucratic restrictions. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:183 / 191
页数:9
相关论文
共 25 条
[1]  
[Anonymous], 1993, The public health impact of needle exchange programs in the United States and abroad
[2]  
Blix O, 1991, DRUG ADDICTION AIDS, P200
[3]   METHADONE-MAINTENANCE AND THE LIKELIHOOD OF RISKY NEEDLE-SHARING [J].
CAPLEHORN, JRM ;
ROSS, MW .
INTERNATIONAL JOURNAL OF THE ADDICTIONS, 1995, 30 (06) :685-698
[4]  
Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P565
[5]   RISK-FACTORS FOR HUMAN-IMMUNODEFICIENCY-VIRUS SEROCONVERSION AMONG OUT-OF-TREATMENT DRUG INJECTORS IN HIGH AND LOW SEROPREVALENCE CITIES [J].
FRIEDMAN, SR ;
JOSE, B ;
DEREN, S ;
JARLAIS, DCD ;
NEAIGUS, A .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 142 (08) :864-874
[6]   NEEDLE EXCHANGE DECREASES THE PREVALENCE OF HIV-1 PROVIRAL DNA IN RETURNED SYRINGES IN NEW-HAVEN, CONNECTICUT [J].
HEIMER, R ;
KAPLAN, EH ;
KHOSHNOOD, K ;
JARIWALA, B ;
CADMAN, EC .
AMERICAN JOURNAL OF MEDICINE, 1993, 95 (02) :214-220
[7]  
HEIMER R, 1994, JAMA-J AM MED ASSOC, V271, P1825
[8]   Hepatitis in used syringes: The limits of sensitivity of techniques to detect hepatitis B virus (HBV) DNA, hepatitis C virus (HCV) RNA, and antibodies to HBV core and HCV antigens [J].
Heimer, R ;
Khoshnood, K ;
JariwalaFreeman, B ;
Duncan, B ;
Harima, Y .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (04) :997-1000
[9]  
Heimer R., 1994, AIDS and Public Policy Journal, V9, P59
[10]  
HEIMER R, 1996, INT J DRUG POLICY, V7, P123